Skip to main content
. 2023 Oct 17;6(4):709–728. doi: 10.20517/cdr.2023.62

Figure 1.

Figure 1

Schematic overview of performed experiments. This figure was created with Biorender.com. HNSCC: Head and neck squamous cell carcinoma; KO: knock-out; -R: cetuximab-resistant HNSCC cell line; -S: cetuximab-sensitive HNSCC cell line.